Carl Spana

Carl Spana

Net worth: 343 686 $ as of 30/09/2026

63 year
Health Technology
Finance
Consumer Services

Profile

Dr. Carl Spana is a President, Chief Executive Officer & Director at Palatin Technologies, Inc. and a President & Director at RhoMed, Inc. He is on the Board of Directors at Palatin Technologies, Inc. and RhoMed, Inc. Dr. Spana was previously employed as an Independent Director by AVAX Technologies, Inc., a Vice President by Castle Group Ltd., a Vice President by Paramount BioCapital Asset Management, Inc., a Vice President by Paramount Capital Investments LLC, and a Research Associate by Bristol Myers Squibb Co. He also served on the board at Microlin Bio, Inc. /Old/.
He received his undergraduate degree from Rutgers State University of New Jersey and a doctorate degree from The Johns Hopkins University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/09/2026 38,747 ( 2.18% ) 343 686 $ 30/09/2026

Carl Spana active positions

CompaniesPositionStart
PALATIN TECHNOLOGIES, INC. Founder 21/11/1986
President -

Former positions of Carl Spana

CompaniesPositionEnd
Corporate Officer/Principal 01/06/1996
Corporate Officer/Principal 01/06/1996
Paramount Capital Investments LLC
Corporate Officer/Principal 01/06/1996
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/06/1993
Director/Board Member -
See the detail of Carl Spana's experience

Education of Carl Spana

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

47

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Commercial Services

Paramount Capital Investments LLC